Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-20-021030
Filing Date
2020-11-12
Accepted
2020-11-12 09:02:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsch13g.htm SC 13G 356589
  Complete submission text file 0001493152-20-021030.txt   358292
Mailing Address C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830
Business Address C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830 475-208-3178
Soleus Private Equity Fund I, L.P. (Filed by) CIK: 0001752427 (see all company filings)

EIN.: 824521410 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto, Inc. (Subject) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91812 | Film No.: 201303812
SIC: 2834 Pharmaceutical Preparations